NEW ANTIVIRAL DRUGS TO CURE CHRONIC HEPATITIS B VIRUS INFECTION

NIH RePORTER · NIH · N43 · $300,000 · view on reporter.nih.gov ↗

Abstract

To support novel therapeutics for hepatitis B virus infection.

Key facts

NIH application ID
10267593
Project number
75N93020C00046-0-9999-1
Recipient
REGULUS THERAPEUTICS, LLC
Principal Investigator
DAVID ROGERS
Activity code
N43
Funding institute
NIH
Fiscal year
2020
Award amount
$300,000
Award type
—
Project period
2020-08-21 → 2021-08-20